Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Eastern Africa

Eastern Africa

The market for Other Vaccines market in Eastern Africa is predicted to witness a significant growth in revenue, with projections indicating that it will reach US$82.85m by the year 2024.
Furthermore, it is expected to exhibit a steady annual growth rate of 10.82% (CAGR 2024-2029), ultimately leading to a market volume of US$138.50m by 2029.
In terms of global comparison, United States is anticipated to generate the highest revenue in this market, amounting to a staggering US$24,730.00m in 2024.
Eastern Africa is experiencing an increasing demand for other vaccines, driven by a growing awareness of the importance of immunization and government initiatives to improve healthcare access.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines has been increasing rapidly in Eastern Africa, with a particular focus on Other Vaccines.

Customer preferences: Customers in Eastern Africa have become more aware of the importance of vaccination in recent years, leading to an increase in demand for Other Vaccines. Additionally, there has been a shift towards preventative healthcare, which has resulted in more people seeking out vaccines to protect themselves against various diseases.

Trends in the market: One of the major trends in the Other Vaccines market in Eastern Africa is the increasing availability of vaccines. Governments and healthcare organizations have been working to improve access to vaccines, which has led to an increase in vaccination rates. Another trend is the growing demand for combination vaccines, which offer protection against multiple diseases in a single shot.

Local special circumstances: Eastern Africa has a high burden of infectious diseases, including malaria, HIV/AIDS, and tuberculosis. This has led to a greater focus on preventative healthcare, including vaccination. Additionally, the region has a large population of young people, who are more likely to be affected by vaccine-preventable diseases.

Underlying macroeconomic factors: The economy in Eastern Africa has been growing steadily in recent years, leading to an increase in disposable income. This has made vaccines more affordable for many people, leading to an increase in demand. Additionally, governments and healthcare organizations have been investing in healthcare infrastructure, which has improved access to vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.